IL17A and Crohn disease: Furthermore, aberrant ILC composition57 and increased IL23-mediated IL17A production by ILCs58 were shown to be associated with Crohn’s disease supporting the notion that ILC activity in the human intestine might be controlled in organized lymphoid structures.